Sirtuin deacylases: a molecular link between metabolism and immunity
暂无分享,去创建一个
[1] A. Akhmedov,et al. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. , 2013, Antioxidants & redox signaling.
[2] G. Feldmann,et al. The NAD+-dependent Histone Deacetylase SIRT6 Promotes Cytokine Production and Migration in Pancreatic Cancer Cells by Regulating Ca2+ Responses* , 2012, The Journal of Biological Chemistry.
[3] C. Deng,et al. Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice* , 2012, The Journal of Biological Chemistry.
[4] D. Green,et al. Metabolic checkpoints in activated T cells , 2012, Nature Immunology.
[5] L. Mcphail,et al. Fueling the flame: bioenergy couples metabolism and inflammation , 2012, Journal of leukocyte biology.
[6] A. Mobasheri,et al. Resveratrol Modulates Interleukin-1β-induced Phosphatidylinositol 3-Kinase and Nuclear Factor κB Signaling Pathways in Human Tenocytes , 2012, The Journal of Biological Chemistry.
[7] S. Ismail,et al. Serum levels of visfatin and omentin‐1 in patients with psoriasis and their relation to disease severity , 2012, The British journal of dermatology.
[8] L. Guarente,et al. High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. , 2012, Cell metabolism.
[9] S. Cho,et al. Chitooligosaccharide Induces Mitochondrial Biogenesis and Increases Exercise Endurance through the Activation of Sirt1 and AMPK in Rats , 2012, PloS one.
[10] Alexander S. Banks,et al. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. , 2012, Physiological reviews.
[11] O. Leo,et al. Complex roles of members of the ADP-ribosyl transferase super family in immune defences: looking beyond PARP1. , 2012, Biochemical pharmacology.
[12] C. McCall,et al. NAD+-dependent Sirtuin 1 and 6 Proteins Coordinate a Switch from Glucose to Fatty Acid Oxidation during the Acute Inflammatory Response* , 2012, The Journal of Biological Chemistry.
[13] J. Auwerx,et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. , 2012, Cell metabolism.
[14] H. Cohen,et al. The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes , 2012, Aging.
[15] Hongwei Yao,et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. , 2012, The Journal of clinical investigation.
[16] M. Ohh,et al. The updated biology of hypoxia‐inducible factor , 2012, The EMBO journal.
[17] R. Johnson,et al. Influence of hypoxia‐inducible factor 1α on dendritic cell differentiation and migration , 2012, European Journal of Immunology.
[18] A. Neyrinck,et al. Sirtuin inhibition attenuates the production of inflammatory cytokines in lipopolysaccharide-stimulated macrophages. , 2012, Biochemical and biophysical research communications.
[19] S. Meroueh,et al. A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53 , 2012, EMBO molecular medicine.
[20] E-C Kim,et al. Mechanical stress‐activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells , 2012, Clinical and experimental immunology.
[21] E. Mazzon,et al. The NAMPT inhibitor FK866 reverts the damage in spinal cord injury , 2012, Journal of Neuroinflammation.
[22] Johan Auwerx,et al. Sirtuins as regulators of metabolism and healthspan , 2012, Nature Reviews Molecular Cell Biology.
[23] J. Wan,et al. Therapeutic benefits of the group B3 vitamin nicotinamide in mice with lethal endotoxemia and polymicrobial sepsis. , 2012, Pharmacological research.
[24] P. Davies,et al. Resveratrol mitigates lipopolysaccharide‐ and Aβ‐mediated microglial inflammation by inhibiting the TLR4/NF‐κB/STAT signaling cascade , 2012, Journal of neurochemistry.
[25] D. Green,et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.
[26] Johan Auwerx,et al. Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase , 2011, Science.
[27] F. Andris,et al. Sirtuin 1 Promotes Th2 Responses and Airway Allergy by Repressing Peroxisome Proliferator-Activated Receptor-γ Activity in Dendritic Cells , 2011, The Journal of Immunology.
[28] M. V. Vander Heiden,et al. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.
[29] S. Imai,et al. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. , 2011, Cell metabolism.
[30] Yi Shi,et al. Inhibition of pre-B cell colony-enhancing factor attenuates inflammation and apoptosis induced by pandemic H1N1 2009 in lung endothelium , 2011, Respiratory Physiology & Neurobiology.
[31] E. Cesarini,et al. Sirtinol Treatment Reduces Inflammation in Human Dermal Microvascular Endothelial Cells , 2011, PloS one.
[32] Zhike Lu,et al. The First Identification of Lysine Malonylation Substrates and Its Regulatory Enzyme* , 2011, Molecular & Cellular Proteomics.
[33] F. Tay,et al. Chronic resveratrol intake reverses pro-inflammatory cytokine profile and oxidative DNA damage in ageing hybrid mice , 2011, AGE.
[34] Matt Kaeberlein,et al. Absence of effects of Sir2 over-expression on lifespan in C. elegans and Drosophila , 2011, Nature.
[35] Michael Detmar,et al. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance , 2011, Annals of the rheumatic diseases.
[36] D. Green,et al. HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.
[37] A. Nikiforov,et al. Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells , 2011, The Journal of Biological Chemistry.
[38] J. Auwerx,et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. , 2011, Cell metabolism.
[39] K. Tracey,et al. HMGB1 is a therapeutic target for sterile inflammation and infection. , 2011, Annual review of immunology.
[40] J. Rathmell,et al. Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.
[41] P. Pandolfi,et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. , 2011, Cancer cell.
[42] L. Guarente,et al. SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production , 2011, Oncogene.
[43] C. McCall,et al. NAD+-dependent SIRT1 Deacetylase Participates in Epigenetic Reprogramming during Endotoxin Tolerance* , 2011, The Journal of Biological Chemistry.
[44] B. Lüscher,et al. SIRT2 regulates NF-κB-dependent gene expression through deacetylation of p65 Lys310 , 2010, Journal of Cell Science.
[45] P. Distefano,et al. SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183. , 2010, Future medicinal chemistry.
[46] P. Elliott,et al. Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis , 2010, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[47] Xiaoling Xu,et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. , 2010, Cell metabolism.
[48] I. Rahman,et al. Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD. , 2010, Archives of biochemistry and biophysics.
[49] Qing Xu,et al. Myeloid Deletion of SIRT1 Induces Inflammatory Signaling in Response to Environmental Stress , 2010, Molecular and Cellular Biology.
[50] Junjie Chen,et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. , 2010, Molecular cell.
[51] Erika L. Pearce. Metabolism in T cell activation and differentiation. , 2010, Current opinion in immunology.
[52] J. Olefsky,et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. , 2010, American journal of physiology. Endocrinology and metabolism.
[53] I. Rahman,et al. PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity. , 2010, Biochemical and biophysical research communications.
[54] S. Honda,et al. Fasting promotes the expression of SIRT1, an NAD+-dependent protein deacetylase, via activation of PPARα in mice , 2010, Molecular and Cellular Biochemistry.
[55] E. Kalkhoven,et al. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. , 2010, Blood.
[56] G. Gores,et al. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. , 2010, The Journal of clinical investigation.
[57] Orian S. Shirihai,et al. The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α , 2010, Cell.
[58] C. Cobelli,et al. Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms , 2010, Diabetes.
[59] R. Garofalo,et al. SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1♦ , 2010, The Journal of Biological Chemistry.
[60] De-Pei Liu,et al. SIRT1 Suppresses Activator Protein-1 Transcriptional Activity and Cyclooxygenase-2 Expression in Macrophages* , 2009, The Journal of Biological Chemistry.
[61] A. Ballestrero,et al. Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE , 2009, PloS one.
[62] K. Tsuneyama,et al. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[63] Brian C. Smith,et al. A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. , 2009, Analytical biochemistry.
[64] M. McBurney,et al. The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. , 2009, The Journal of clinical investigation.
[65] S. Biswas,et al. Endotoxin tolerance: new mechanisms, molecules and clinical significance. , 2009, Trends in immunology.
[66] L. Altucci,et al. Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. , 2009, Journal of medicinal chemistry.
[67] P. Elliott,et al. A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9 , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] Karine Gilbert,et al. The Small Molecule GMX1778 Is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors , 2009, Molecular and Cellular Biology.
[69] Bo Yang,et al. The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability , 2009, Cell cycle.
[70] C. Deng,et al. Recent progress in the biology and physiology of sirtuins , 2009, Nature.
[71] A. Harris,et al. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. , 2009, Blood.
[72] K. Tsubota,et al. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. , 2009, Investigative Ophthalmology and Visual Science.
[73] R. Chen,et al. Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1 , 2009, Science.
[74] P. Puigserver,et al. GCN5-mediated Transcriptional Control of the Metabolic Coactivator PGC-1β through Lysine Acetylation* , 2009, The Journal of Biological Chemistry.
[75] K. Birukov,et al. SIRT1 Promotes Cell Survival under Stress by Deacetylation-Dependent Deactivation of Poly(ADP-Ribose) Polymerase 1 , 2009, Molecular and Cellular Biology.
[76] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[77] J. Tyler,et al. CBP/p300-mediated acetylation of histone H3 on lysine 56 , 2009, Nature.
[78] Zheng Shen,et al. Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[79] Takashi Nakagawa,et al. SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea Cycle , 2009, Cell.
[80] Amy V. Lynch,et al. Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators. , 2009, Bioorganic & medicinal chemistry letters.
[81] Qing Xu,et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. , 2009, Cell metabolism.
[82] Kirk C. Hansen,et al. CBP / p300-mediated acetylation of histone H3 on lysine 56 , 2009, Nature.
[83] B. K. Thakur,et al. NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD+-sirtuin-1-dependent pathway. , 2009 .
[84] Amy V. Lynch,et al. Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators. , 2009, Journal of medicinal chemistry.
[85] Véronique Kruys,et al. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner , 2009, Nature Medicine.
[86] A. Schambach,et al. NAMPT is essential for the G-CSF–induced myeloid differentiation via a NAD+–sirtuin-1–dependent pathway , 2009, Nature Medicine.
[87] Howard Y. Chang,et al. SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span , 2009, Cell.
[88] J. D. de Sanctis,et al. Serum adipokine levels in patients with systemic lupus erythematosus , 2009, Autoimmunity.
[89] J. Olefsky,et al. SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes , 2008, Molecular and Cellular Biology.
[90] N. Maulik,et al. Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity. , 2008, Journal of agricultural and food chemistry.
[91] W. Staines,et al. sirt1-null mice develop an autoimmune-like condition. , 2008, Experimental cell research.
[92] Shiwei Song,et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis , 2008, Proceedings of the National Academy of Sciences.
[93] P. Pfluger,et al. Sirt1 protects against high-fat diet-induced metabolic damage , 2008, Proceedings of the National Academy of Sciences.
[94] O. Leo,et al. Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD , 2008, PloS one.
[95] E. Hoffman,et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. , 2008, Developmental cell.
[96] F. Berenbaum,et al. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. , 2008, Arthritis and rheumatism.
[97] Chia-Fang Liu,et al. The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation. , 2008, Biomaterials.
[98] I. Rahman,et al. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[99] Howard Y. Chang,et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin , 2008, Nature.
[100] W. Greene,et al. Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. , 2008, Cell host & microbe.
[101] S. Ghosh,et al. Shared Principles in NF-κB Signaling , 2008, Cell.
[102] M. Nagarkatti,et al. Resveratrol (trans-3,5,4′-Trihydroxystilbene) Ameliorates Experimental Allergic Encephalomyelitis, Primarily via Induction of Apoptosis in T Cells Involving Activation of Aryl Hydrocarbon Receptor and Estrogen Receptor , 2007, Molecular Pharmacology.
[103] Amy V. Lynch,et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.
[104] J. Milbrandt,et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. , 2007, Cell metabolism.
[105] R. Nazar,et al. Borrowing from Biology , 2007, Science.
[106] B. Spiegelman,et al. Skeletal Muscle Fiber-type Switching, Exercise Intolerance, and Myopathy in PGC-1α Muscle-specific Knock-out Animals* , 2007, Journal of Biological Chemistry.
[107] Dudley Lamming,et al. Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival , 2007, Cell.
[108] S. Imai,et al. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals , 2007, Current opinion in gastroenterology.
[109] I. Rahman,et al. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[110] R. Swanson,et al. Use of a Poly(ADP-Ribose) Polymerase Inhibitor to Suppress Inflammation and Neuronal Death After Cerebral Ischemia-Reperfusion , 2007, Stroke.
[111] L. Guarente,et al. SIRT1 Inhibits Transforming Growth Factor β-Induced Apoptosis in Glomerular Mesangial Cells via Smad7 Deacetylation* , 2007, Journal of Biological Chemistry.
[112] P. Puigserver,et al. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.
[113] T. White,et al. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. , 2006, Biochemical and biophysical research communications.
[114] F. Alt,et al. SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells , 2006, Cell.
[115] Eric Verdin,et al. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2 , 2006, Proceedings of the National Academy of Sciences.
[116] H. Cui,et al. Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1β (IL-1β) in astrocyte cultures , 2006, Journal of Neuroimmunology.
[117] R. DePinho,et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. , 2006, Cancer research.
[118] M. Sánchez-Hidalgo,et al. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model , 2006, British journal of pharmacology.
[119] Pingfang Liu,et al. Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2006, Cell.
[120] J. Gómez-Reino,et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis , 2006, Annals of the rheumatic diseases.
[121] S. Imai,et al. Poly(ADP-ribose) Polymerase-1-dependent Cardiac Myocyte Cell Death during Heart Failure Is Mediated by NAD+ Depletion and Reduced Sir2α Deacetylase Activity* , 2005, Journal of Biological Chemistry.
[122] D. Fuchs,et al. Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro. , 2005, Immunology letters.
[123] M. Matsuda,et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.
[124] Y. Turkoz,et al. Effect of resveratrol in experimental osteoarthritis in rabbits , 2005, Inflammation Research.
[125] Wilhelm Haas,et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.
[126] T. Standiford,et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. , 2005, American journal of respiratory and critical care medicine.
[127] Q. Ma,et al. Effect of resveratrol on activation of nuclear factor kappa-B and inflammatory factors in rat model of acute pancreatitis. , 2005, World journal of gastroenterology.
[128] S. Imai,et al. The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* , 2004, Journal of Biological Chemistry.
[129] Brian C. Smith,et al. Coenzyme Specificity of Sir2 Protein Deacetylases , 2004, Journal of Biological Chemistry.
[130] M. Mayo,et al. Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.
[131] J. Marshall,et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. , 2004, The Journal of clinical investigation.
[132] Steven P. Gygi,et al. Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.
[133] A. Sollevi,et al. Nicotinamide does not influence cytokines or exhaled NO in human experimental endotoxaemia , 2004, Clinical and experimental immunology.
[134] F. Andris,et al. Reconstructing eukaryotic NAD metabolism. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[135] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[136] R. Korthuis,et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. , 2003, Free radical biology & medicine.
[137] J. Denu,et al. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. , 2003, Molecular cell.
[138] M. Blombäck,et al. Nicotinamide is a potent inhibitor of proinflammatory cytokines , 2003, Clinical and experimental immunology.
[139] D. Sinclair,et al. Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1* , 2002, The Journal of Biological Chemistry.
[140] D. Gigot,et al. Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis , 2002, European journal of immunology.
[141] E. Verdin,et al. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide–dependent deacetylase , 2002, The Journal of cell biology.
[142] A. Yakovlev,et al. Roles of DNA fragmentation factor and poly(ADP-ribose) polymerase in an amplification phase of tumor necrosis factor-induced apoptosis. , 2001, The Journal of biological chemistry.
[143] H. Inui,et al. Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice. , 2001, Journal of NutriLife.
[144] R. Frye,et al. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. , 2000, Biochemical and biophysical research communications.
[145] Rick B. Vega,et al. The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.
[146] L. Guarente,et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase , 2000, Nature.
[147] J. Satoh,et al. Inhibitory effect of nicotinamide on in vitro and in vivo production of tumor necrosis factor-alpha. , 1997, Immunology Letters.
[148] I McNiece,et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.
[149] G. Murcia,et al. Identification of potential active-site residues in the human poly(ADP-ribose) polymerase. , 1993, The Journal of biological chemistry.
[150] P. Langcake,et al. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury , 1976 .
[151] C. Elvehjem,et al. FACTORS AFFECTING THE GROWTH OF RATS RECEIVING NIACIN-TRYPTOPHAN-DEFICIENT DIETS , 1947 .
[152] P. Elliott,et al. Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. , 2013, British journal of clinical pharmacology.
[153] Yu-guang Du,et al. Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress. , 2011, International immunopharmacology.
[154] Robert V Farese,et al. SIRT 3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation , 2010 .
[155] B. Lüscher,et al. SIRT 2 regulates NFk B-dependent gene expression through deacetylation of p 65 Lys 310 , 2010 .
[156] M. Perretti,et al. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase , 2001, Inflammation Research.
[157] L. Peshkin,et al. Supplemental Data Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span , 2008 .